Control Bionics (ASX:CBL) Interest Expense: A$-0.10 Mil (TTM As of Dec. 2025)


What is Control Bionics Interest Expense?

Control Bionics ASX:CBL +3.47% Interest Expense is A$-0.10 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Control Bionics's interest expense for the six months ended in Dec. 2025 was A$ -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Control Bionics's Operating Income for the six months ended in Dec. 2025 was A$ -3.73 Mil. Control Bionics's Interest Expense for the six months ended in Dec. 2025 was A$ -0.05 Mil. Control Bionics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Control Bionics  (ASX:CBL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Control Bionics's Interest Expense for the six months ended in Dec. 2025 was A$-0.05 Mil. Its Operating Income for the six months ended in Dec. 2025 was A$-3.73 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was A$0.02 Mil.

Control Bionics's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Control Bionics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Control Bionics Interest Expense Historical Data

* Premium members only.

The historical data trend for Control Bionics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Interest Expense Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Interest Expense
Get a 7-Day Free Trial -0.03 -0.01 -0.01 -0.06 -0.11

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.04 -0.06 -0.05 -0.05

Control Bionics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of A$-0.10 Mil mean?
Control Bionics (ASX:CBL) has a Interest Expense of A$-0.10 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Control Bionics and its competitors.
Is Control Bionics' Interest Expense too high?
Control Bionics' current Interest Expense is A$-0.10 Mil.
How does Control Bionics' Interest Expense compare to ABT and SYK?
Control Bionics' Interest Expense of A$-0.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Control Bionics and its competitors. Control Bionics's current Interest Expense is A$-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.07 — trading 148.3% above its estimated fair value. The current Interest Expense is A$-0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Interest Expense is A$-0.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.